BSE filing, NSE: WINDLAS. Summary written from the filing by ALFA Finder's alert engine.
Windlas Biotech Ltd: key numbers
- Share price
- ₹881.10
- Market cap
- ₹1,849 Cr
- Revenue (annual)
- ₹904.1 Cr
- Net profit (annual)
- ₹66.44 Cr
- P/E (TTM)
- 27.8×Sector 48.7×
- Promoter holding
- 63.31%+0.00% QoQ
- FII holding
- 2.09%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Windlas Biotech Ltd
All →Windlas Biotech Board Meeting Date
Windlas Biotech intimated that its Board meeting is scheduled for 5 November 2026 to consider unaudited standalone results for Q1 FY27. No monetary figure is disclosed in this advance notice.
Windlas Biotech Management Change
Windlas Biotech appointed Aashish Mehra and Soni Saran Singh as Independent Directors. Vivek Dhariwal resigned as Independent Director and Chairman of the Board.
Windlas Biotech Earnings Call Transcript: Key Takeaways
Windlas Biotech reported record quarterly revenue driven by 29% growth in CDMO vertical. Management focuses on operational excellence and capacity expansion via Plant 6 commercialization.
Windlas Biotech Results Update
Windlas Biotech reported Q1 FY27 revenue of Rs 248 crore, an 18% YoY growth. The release highlights an adjusted EBITDA of Rs 34 crore and PAT of Rs 25 crore.
Windlas Biotech Investor Presentation: Key Takeaways
Windlas Biotech reported Q1FY27 revenue of ₹248 Cr (18% YoY). Adjusted EBITDA and PAT grew 26% and 37% respectively, excluding ESOP costs, driven by CDMO expansion.
Windlas Biotech Q1 FY27 Results: Net Profit ₹17.7 Cr, Up 0.0% YoY
Windlas Biotech Ltd reported revenue from operations of ₹248.1 Cr (+18.1% YoY) and net profit of ₹17.7 Cr (+0.0% YoY) for Q1 FY27.
- Key figure
- Net profit ₹17.7 Cr · +0.0% YoY
Other other announcement announcements
All →S.K. Offset Other Announcement
S.K. Offset Ltd submitted a non-applicability certificate for Related Party Transactions under Reg 23. The firm confirmed its capital and net worth fall below the compliance thresholds.
Aditya Birla Capital Other Announcement
Aditya Birla Capital filed a quarterly Monitoring Agency Report confirming no deviation in utilizing its ₹4,000 Crore Preferential Issue proceeds. The filing covers the quarter ended 30 September 2026.
Sarda Energy & Minerals Other Announcement
Sarda Energy & Minerals re-filed its quarterly shareholding pattern for the quarter ended 30 September 2026. The filing shows promoter and promoter group holdings and public category breakdowns with no transaction or money involved.
Sasken Technologies Other Announcement
Sasken Technologies re-filed its quarterly shareholding pattern for the quarter ended 30 September 2026. It corrects a promoter name interchange and reports no change in holdings.
Behari Lal Engineering Other Announcement
Behari Lal Engineering filed its quarterly shareholding pattern for the period ended 30 September 2026. Promoter and promoter group hold 70.84% of the equity.
Punjab Chemicals and Crop Protection Other Announcement
Punjab Chemicals & Crop Protection filed its quarterly shareholding pattern as of 30 September 2026 under Regulation 31(1)(b). It is a periodic compliance statement with no transaction, money or corporate event.